Balance Sheet for Cytokinetics Incorporated (CYTK)

$ 13.17   0.12 (+0.92%) Volume: 388.88k 4:00 PM EDT 19-Sep-2019
After Hours:  $ 13.17 0.00 (0.00%) Volume: 5.57k 5:07 PM EDT 19-Sep-2019
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 42,256 125,206 66,874 65,076 20,215
Restrictable Cash - - - - -
Marketable Securities 156,475 143,685 89,375 46,366 63,013
Accounts Receivable 2,231 1,112 24 12 46,646
Loans Receivable - - - - -
Other Receivables 4,554 - - - -
Receivables 6,785 1,112 24 12 46,646
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 2,158 4,292 2,360 1,653 1,257
Current Deferred Income Taxes - - - - -
Other Current Assets 8,943 4,292 2,360 1,653 1,257
Total Current Assets 207,674 274,295 158,633 113,107 131,131
Land and Improvements - - - - -
Buildings and Improvement 5,130 5,067 4,458 3,425 3,334
Machinery, Furniture and Equipment 21,935 21,127 20,297 19,168 18,630
Construction in Progress - - - - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 27,065 26,194 24,755 22,593 21,964
Gross Fixed Assets 27,065 26,194 24,755 22,593 21,964
Accumulated Depreciation (23,861) (22,626) (21,118) (20,842) (20,327)
Net Fixed Assets 3,204 3,568 3,637 1,751 1,637
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 300 429 200 200 200
Total Non-Current Assets 3,504 20,515 11,509 2,130 1,837
Total Assets 211,178 294,810 170,142 115,237 132,968
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 3,764 5,253 4,236 2,238 1,361
Short Term Debt 2,607 21,969 2,500 - -
Notes Payable - - - - -
Accrued Expenses 9,639 11,131 18,047 8,421 5,400
Accrued Liabilities 9,639 11,131 18,047 8,421 5,400
Deferred Revenues - 9,572 8,060 20,858 17,042
Current Deferred Income Taxes - - - - -
Other Current Liabilities 6,184 (15,481) 415 132 52
Total Current Liabilities 22,194 32,444 33,258 31,649 23,855
Long Term Debt 39,806 31,777 27,381 14,639 -
Deferred Income Tax - 15,000 15,000 359 17,049
Other Non-Current Liabilities 123,244 120,747 15,142 359 17,049
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 163,050 152,524 42,523 14,998 17,049
Total Liabilities 185,244 184,968 75,781 46,647 40,904
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 25,934 109,842 94,361 68,590 92,064
Common Par 55 54 41 40 39
Additional Paid in Capital 768,703 755,526 612,474 603,145 589,272
Cumulative Translation Adjustments - - - - -
Retained Earnings (743,324) (646,081) (518,291) (534,744) (497,243)
Treasury Stock - - - - -
Other Equity Adjustments 500 343 137 149 (4)
Total Capitalization 65,740 141,619 121,742 83,229 92,064
Total Equity 25,934 109,842 94,361 68,590 92,064
Total Liabilities & Shareholder's Equity 211,178 294,810 170,142 115,237 132,968
Cash Flow (106,289) (127,790) 16,453 (37,501) (14,646)
Working Capital 185,480 241,851 125,375 81,458 107,276
Free Cash Flow (102,104) (104,636) 35,386 4,321 (45,947)
Invested Capital 65,740 141,619 121,742 83,229 92,064
Shares Outstanding - Common Class Only 54,718 53,961 40,647 39,582 38,660
Preferred Shares Outstanding 4 4 4 4 4
Total Ordinary Shares 54,718 53,961 40,647 39,582 38,660
Total Common Shares Outstanding 54,718 53,961 40,647 39,582 38,660
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 54,420 49,404 39,943 38,814 35,709
Diluted Weighted Shares Outstanding 54,420 49,404 42,561 38,814 35,709